| P50 | author | Beatriz Martínez | Q43121459 |
| | Eva González-Menéndez | Q59690919 |
| | Lucía Fernández | Q40177912 |
| P2093 | author name string | Ana Rodríguez | |
| | Pilar García | |
| | Diana Gutiérrez | |
| | Daniel Pando | |
| P2860 | cites work | Bacteriophage performance against Staphylococcus aureus in milk is improved by high hydrostatic pressure treatments | Q60182833 |
| | Phage inactivation of Staphylococcus aureus in fresh and hard-type cheeses | Q60182838 |
| | Release of enzymes from liposomes during cheese ripening | Q77184356 |
| | A targeted liposome delivery system for combretastatin A4: formulation optimization through drug loading and in vitro release studies | Q79335906 |
| | Removal of Listeria monocytogenes biofilms with bacteriophage P100 | Q84985767 |
| | Resveratrol entrapped niosomes as yoghurt additive | Q85756328 |
| | Encapsulation of nisin and lysozyme in liposomes enhances efficacy against Listeria monocytogenes | Q44901769 |
| | Current Demands for Food-Approved Liposome Nanoparticles in Food and Safety Sector | Q47116108 |
| | Encapsulation of Listeria Phage A511 by Alginate to Improve Its Thermal Stability. | Q50036621 |
| | Direct feeding of microencapsulated bacteriophages to reduce Salmonella colonization in pigs | Q50038045 |
| | Bacteriophage treatment reduces Salmonella colonization of infected chickens | Q50062157 |
| | Prevalence of bacteriophages infecting Staphylococcus aureus in dairy samples and their potential as biocontrol agents. | Q54477356 |
| | Oral peptide delivery by tetraether lipid liposomes. | Q55054517 |
| | Enhancement of Lactobacillus reuteri KUB-AC5 survival in broiler gastrointestinal tract by microencapsulation with alginate-chitosan semi-interpenetrating polymer networks | Q57110079 |
| | Microfluidic-assisted bacteriophage encapsulation into liposomes | Q59348988 |
| | Diffusion of univalent ions across the lamellae of swollen phospholipids | Q59447717 |
| | Phage Therapy in Clinical Practice: Treatment of Human Infections | Q22061778 |
| | A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa ; a preliminary report of efficacy | Q22061813 |
| | Bacteriophages as Weapons Against Bacterial Biofilms in the Food Industry | Q26745094 |
| | Staphylococcus aureus infections | Q28131787 |
| | Encapsulation of Bacteriophage in Liposome Accentuates Its Entry in to Macrophage and Shields It from Neutralizing Antibodies | Q28551599 |
| | Using phage lytic enzymes to control pathogenic bacteria | Q33255357 |
| | Current status of pH-sensitive liposomes in drug delivery | Q34084752 |
| | Reduction of Campylobacter jejuni in broiler chicken by successive application of group II and group III phages. | Q34663447 |
| | Application of bacteriophages to control intestinal Escherichia coli O157:H7 levels in ruminants | Q34973928 |
| | Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial. | Q34996099 |
| | Phages in nature | Q35029210 |
| | Staphylococcus aureus and food poisoning | Q35199279 |
| | Two Phages, phiIPLA-RODI and phiIPLA-C1C, Lyse Mono- and Dual-Species Staphylococcal Biofilms. | Q35529858 |
| | Liposome-Encapsulated Bacteriophages for Enhanced Oral Phage Therapy against Salmonella spp | Q35625761 |
| | Liposomal-encapsulated Ascorbic Acid: Influence on Vitamin C Bioavailability and Capacity to Protect Against Ischemia-Reperfusion Injury | Q37025977 |
| | Advances in MRSA drug discovery: where are we and where do we need to be? | Q37112508 |
| | Bacteriophages and their application in food safety. | Q37361648 |
| | Phage and their lysins as biocontrol agents for food safety applications | Q37963048 |
| | Niosomes from 80s to present: the state of the art. | Q38173878 |
| | Microencapsulation of bioactives for food applications | Q38364782 |
| | Microencapsulation of new probiotic formulations for gastrointestinal delivery: in vitro study to assess viability and biological properties. | Q38846692 |
| | Formulation, stabilisation and encapsulation of bacteriophage for phage therapy. | Q39422844 |
| | Phospholipid vesicles encapsulated bacteriophage: A novel approach to enhance phage biodistribution | Q40620190 |
| | The potential of the endolysin Lysdb from Lactobacillus delbrueckii phage for combating Staphylococcus aureus during cheese manufacture from raw milk | Q41085155 |
| | Efficacy of two Staphylococcus aureus phage cocktails in cheese production. | Q41206448 |
| | Use of logistic regression for prediction of the fate of Staphylococcus aureus in pasteurized milk in the presence of two lytic phages | Q42087888 |
| | Use of Pistacia terebinthus resin as immobilization support for Lactobacillus casei cells and application in selected dairy products | Q42970355 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | virology | Q7215 |
| | infectious disease | Q18123741 |
| | bacteriophage | Q165028 |
| P304 | page(s) | 495 | |
| P577 | publication date | 2018-09-13 | |
| P1433 | published in | Viruses | Q7935305 |
| P1476 | title | Strategies to Encapsulate the Staphylococcus aureus Bacteriophage phiIPLA-RODI | |
| P478 | volume | 10 | |